Force Therapeutics Joins the American Academy of Orthopaedic Surgeons' PROMs Vendor Program

Force Therapeutics Participates in AAOS PROMs Vendor Program

New York, June 4, 2025 – Force Therapeutics has been honored to be selected as a participant in the American Academy of Orthopaedic Surgeons (AAOS) PROMs Vendor Program. This esteemed recognition emphasizes the company's commitment to aid clinicians in implementing and utilizing patient-reported outcome measures (PROMs) directly at the point of care.

The rise of value-based care has created a pivotal shift in how healthcare providers approach patient outcomes. In light of this, Force Therapeutics seeks to simplify the process of outcome reporting, thereby facilitating improved clinical decisions. "Finding the right technology vendor who can efficiently assist with collecting patient-reported outcome data is vital but often daunting," remarks Kurt P. Spindler, MD, FAAOS, who chairs the AAOS PROMs workgroup. He added, "We are thrilled to welcome Force Therapeutics into our circle of featured PROMs vendors and look forward to collaborating with AAOS members during the PROMs implementation process."

Bronwyn Spira, CEO of Force Therapeutics, expressed pride in the recognition. "We are dedicated to supporting care teams with scalable PROMs collection. Our aim is to drive better clinical decisions while enhancing overall patient care."

What the PROMs Vendor Program Means

The AAOS PROMs Vendor Program selects participants based on a comprehensive set of criteria. This includes evaluating the vendor's capability to collect and submit patient-reported outcomes data, a proven history of data submission to AAOS registries, and assessments of other relevant information. This rigorous vetting process ensures that the selected vendors maintain high standards and offer reliable solutions that contribute positively to patient care.

By being part of this program, Force Therapeutics showcases its expertise in managing patient engagement and their commitment to improving surgical care outcomes. The company offers a patient engagement solution and care coordination software tailored specifically for individuals undergoing specialty procedures.

The Role of Force Therapeutics

Force Therapeutics aims to enhance patient engagement and satisfaction while significantly improving clinical outcomes. The company leverages data-driven tools and automated clinical workflows to reduce variations in care and improve efficiency across hospitals, Ambulatory Surgery Centers (ASCs), and health systems. By focusing on clinically validated remote patient care, Force Therapeutics empowers healthcare providers to make more informed decisions and ultimately leads to better patient satisfaction.

About the American Academy of Orthopaedic Surgeons

The AAOS stands as the largest medical association focused on musculoskeletal specialists worldwide, boasting over 39,000 members. The organization is a trusted source for advancing musculoskeletal health and prides itself on delivering the highest quality education to orthopedic surgeons and allied health professionals. By maintaining a robust presence in health care discussions surrounding bone and joint conditions, AAOS serves as a hallmark for both treatment methodologies and advancements in musculoskeletal health care.

In conclusion, Force Therapeutics’ recognition as part of the AAOS PROMs Vendor Program reflects its commitment to enhancing the quality of orthopedic care through innovative approaches aimed at redefining patient engagement and outcome reporting. This partnership promises significant advancements in how patient-reported outcomes are managed and utilized in clinical settings, aligning with the future of value-based care.